Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03465904 · ClinicalTrials.gov registry record · NA

A Phase III Trial of e-TNS for the Acute Treatment of Migraine

A NA study of Migraine, sponsored by Cefaly Technology.

Completed
Registry status
NA
Development phase
607
Enrollment target
10
Study locations

NCT03465904 is a NA study of Migraine that has completed, run by Cefaly Technology. The registered enrollment target is 607 participants, above the 352-participant average among 102 other Migraine trials with a reported enrollment target (72% higher). The trial reports 10 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03465904, a NA study of Migraine, has completed, sponsored by Cefaly Technology.

COMPLETED
Registry status
NA
Development phase
607 participants
Enrollment target
10
Study locations

Study Summary

The main objective of this study is to have Phase III evidences of the efficacy of the Cefaly® Abortive Program device used at home for 2 hours to treat a migraine attack. This randomized, double-blind, sham-controlled trial will study the abortive treatment of migraine using the Cefaly® Abortive Program device.

Conditions Studied

Migraine

Interventions

  • DEVICE Verum Cefaly® Abortive Program device
  • DEVICE Sham Cefaly® Abortive Program device

Study Locations (10)

Arizona

  • Clinical Research Consortium - Tempe

California

  • Pharmacology Research Institute - Encino

Connecticut

  • Yale University - New Haven

Florida

  • Palm Beach Research Center - West Palm Beach

Georgia

  • Meridian Clinical Research (Savannah Neurology) - Savannah

Maryland

  • Meridian Clinical Research (Rockville Neurology) - Rockville

Nevada

  • Clinical Research Consortium - Las Vegas

New York

  • Rochester Clinical Research - Rochester

Trial Details

FieldValue
Enrollment Target 607 participants
Start Date 2018-04-10
Est. Completion 2019-01-11
Phase NA

Sponsor

Cefaly Technology

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03465904

The ClinicalTrials.gov registry entry for NCT03465904 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 607 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 352-participant average among 102 other Migraine trials with a reported enrollment target (72% higher). The listed sponsor is Cefaly Technology, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 2 interventions - of which Verum Cefaly® Abortive Program device is the first listed.

NCT03465904 reports 10 study locations spanning 10 distinct geographic areas - top geographies include Arizona, California, Connecticut.

Frequently Asked Questions

What is clinical trial NCT03465904 about?

NCT03465904 is a clinical study titled "A Phase III Trial of e-TNS for the Acute Treatment of Migraine". The main objective of this study is to have Phase III evidences of the efficacy of the Cefaly® Abortive Program device used at home for 2 hours to treat a migraine attack. This randomized, double-blind, sham-controlled trial will study the abortive treatment of migraine using the Cefaly® Abortive Pr...

What is the current status of trial NCT03465904?

This trial is currently completed. It is a NA study. The enrollment target is 607 participants. The study started on 2018-04-10. Estimated completion is 2019-01-11.

What conditions does trial NCT03465904 study?

This clinical trial studies the following conditions: Migraine.

What interventions are being tested in trial NCT03465904?

The interventions under investigation include: Verum Cefaly® Abortive Program device (DEVICE), Sham Cefaly® Abortive Program device (DEVICE).

Who is sponsoring clinical trial NCT03465904?

This trial is sponsored by Cefaly Technology, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03465904 being conducted?

This trial has 10 study locations across Arizona, California, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Migraine

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.